Liposomal Clodronate as a Therapy for Autoimmune Hemolytic Anemia

Tech ID: 02-07

NOTE: THIS TECHNOLOGY IS EXPERIMENTAL AND THEREFORE IT IS NOT AVAILABLE TO HUMANS. IT HAS ONLY BEEN TESTED IN MICE AND DOGS DIAGNOSED WITH AIHA

Summary - This invention is using liposomal clodronate as a therapy for autoimmune hemolytic anemia (AIHA).

Potential Applications

  • Therapy for autoimmune hemolytic anemia
  • The therapy is applicable to both humans and companion animals

Advantages of Invention

  • The method is less invasive than surgery (splenectomy)
  • Decrease use of steroids
  • Decrease side effects

State of Development

  • The efficacy of this therapy has been demonstrated by some strong in vivo data obtained in mice and dogs with AIHA.
  • Using a mouse model in which animals were given anti red blood cell antibodies, treatment with liposomal clodronate substantially decreased red blood cell destruction.
  • In addition, this effect was detected within hours and lasted at least a week.

Further R&D Required - Additional in vivo studies with other animal models.

Licensing Potential - Available for licensing.

Patent Status - U.S. Patent #7,090,865

Inventors - Mike Jordan, MD, Philippa Marrack, PhD and John Kappler, PhD

Publications

 

 

02-07a RBC clearance and the effects of LC treatment in dogs with AIHA. RBC clearance in 6 dogs with spontaneous AIHA was assessed by flow cytometry prior to treatment and again 24 hours after treatment with LC and the mean (± SE) percentage of labeled RBC present in circulation at each time point post infusion was determined. (B) RBC clearance kinetics were determined again 24 hours after treatment with 0.5 mL/kg LC. In 4 dogs (Nonresponders), there was no change in RBC clearance compared to clearance prior to treatment with LC, whereas in 2 dogs (Responders), RBC clearance was markedly reduced.

 

 

For Further Information, Contact:
Emmanuel Hilaire, PhD
Manager
Technology Transfer Office
National Jewish Health
1400 Jackson Street, Room M206b
Denver, CO 80206
Voice: (303) 398-1262
Fax: (303) 270-2352
HilaireE@njhealth.org


1-800-222-5864
Refer a Patient

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our A-Z directory of Faculty by Area of Research.